247 related articles for article (PubMed ID: 18975328)
21. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
[TBL] [Abstract][Full Text] [Related]
22. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
[TBL] [Abstract][Full Text] [Related]
23. Cellular mechanisms in inflammatory myopathies.
Hohlfeld R; Goebels N; Engel AG
Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
25. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
Murata K; Dalakas MC
Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
[TBL] [Abstract][Full Text] [Related]
26. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
27. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
28. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
Greenberg SA; Pinkus JL; Pinkus GS; Burleson T; Sanoudou D; Tawil R; Barohn RJ; Saperstein DS; Briemberg HR; Ericsson M; Park P; Amato AA
Ann Neurol; 2005 May; 57(5):664-78. PubMed ID: 15852401
[TBL] [Abstract][Full Text] [Related]
29. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
[TBL] [Abstract][Full Text] [Related]
31. Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study.
Yang HY; Chu M; Zheng LW; Zwahlen RA; Luo J; Zou DH; Sun ST
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):721-8. PubMed ID: 18929994
[TBL] [Abstract][Full Text] [Related]
32. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
[TBL] [Abstract][Full Text] [Related]
33. Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo.
Schreiner B; Wischhusen J; Mitsdoerffer M; Schneider D; Bornemann A; Melms A; Tolosa E; Weller M; Wiendl H
Glia; 2003 Dec; 44(3):296-301. PubMed ID: 14603470
[TBL] [Abstract][Full Text] [Related]
34. 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells.
Zhou YH; Chen YJ; Ma ZY; Xu L; Wang Q; Zhang GB; Xie F; Ge Y; Wang XF; Zhang XG
Tissue Antigens; 2007 Aug; 70(2):96-104. PubMed ID: 17610414
[TBL] [Abstract][Full Text] [Related]
35. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
36. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
37. Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies.
De Paepe B; Racz GZ; Schröder JM; De Bleecker JL
Acta Neuropathol; 2004 Jul; 108(1):37-42. PubMed ID: 15138776
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.
Paepe BD; Creus KK; Weis J; Bleecker JL
Neuromuscul Disord; 2012 Jan; 22(1):26-33. PubMed ID: 21855341
[TBL] [Abstract][Full Text] [Related]
39. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
Tateyama M; Fujihara K; Misu T; Itoyama Y
J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
[TBL] [Abstract][Full Text] [Related]
40. Plasma cells in muscle in inclusion body myositis and polymyositis.
Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
